Press Room

Event

IFPAC 2023

Start
Sunday, June 04, 2023 - 00:00
End
Wednesday, June 07, 2023 - 00:00
Location: Maryland, USA

Hovione is present at the International Forum Process Analytical Technology (IFPAC), a forum that brings the latest trends and real-life applications in the fields of Quality by Design, Process Analytical Technology, Emerging Technologies, Quality Metrics, Continuous Manufacturing and Process Control applications for the pharmaceutical industry, biotechnology, generic, chemical and related industries.

 

HOVIONE PRESENTATIONS

Hovione experts share their knowledge at IFPAC® - 37th International Forum Process Analytical Technology
June 4-7, 2023 | North Bethesda, Maryland (Washington D.C.)

 

June 6: Grand Ballroom G | 4:50 PM - 5:15 PM
Part of session: Recent Developments to Realizing Continuous Manufacturing
Presentation Title: Use of Statistical Process Control to drive process improvements in continuous manufacturing
Primary presenter: Fernando Barros

 

June 7: Grand Ballroom C | 7:50 AM - 12:00 PM
Session: Defining Incentives and Business Cases for PAT - Defining the Boundaries between Batch & Continuous Manufacturing
Chair: Anthony Tantuccio

 

June 7: Glen Echo Conference Room | 11:10 AM - 11:35 AM
Part of session: Enhanced Analytical Approaches & Modeling for Process Optimization
Presentation Title: A template for investigating NIR spectroscopy-based deviations
Primary presenter: Fernando Barros

 

June 7: White Flint Amphitheatre | 1:05 PM - 5:40 PM
Part of session: Continued Process Verification (CPV) - Practices, Challenges and Opportunities
Presentation Title: Enhance Spray Drying CPV using MVDA
Primary presenter: Tiago Porfirio
 

One approach to enhancing Continued process verification (CPV) is through the use of multivariate data analysis (MVDA), which allows for the identification of correlations and patterns between process parameters and product quality attributes. MVDA involves the analysis of multiple variables simultaneously, allowing for a comprehensive understanding of the process and its impact on product quality. By analyzing data from multiple sources, including automated control systems and quality control testing, MVDA can help identify the critical process parameters (CPPs) and critical quality attributes (CQAs) that are most strongly correlated with product quality. This approach can significantly improve process efficiency and product quality while reducing the risk of product failure, reprocessing and rework. Moreover, MVDA provide insights into potential causes for process deviations, facilitating the development of corrective actions. This proactive approach to CPV helps to ensure that the process remains within established control limits, minimizing the risk of non-compliance. This work will show how the integration of MVDA into CPV in a spray drying process can significantly enhance process control and product quality by leveraging multivariate data analysis.
 

 

 

Meet our experts. Let’s discuss your project together.

 

 

Find more about IFPAC.

 

 

Also in the Press Room

See All

Twenty companies presented at the annual kickoff to DCAT Week. The Drug, Chemical & Associated Technologies Association (DCAT) opened DCAT Week 2026 with its Member Company Announcement Forum. The kickoff to the annual event in New York City, underway from March 23–26, 2026, showcased 20 companies. These were selected based on their announcements’ “news priority, criticality, and interest” to DCAT member companies. The following is a summary of highlights from the presentations, supplemented by additional information provided by some of the companies. (...) Hovione Hovione’s Vice President of Technical Operations for the Americas, David Basile, delivered the company’s Member Company Announcement Forum presentation. Basile will be speaking exclusively with Contract Pharma during DCAT Week, so check back for more on Hovione’s latest.   Read the full article at ContractPharma.com    

Press Clipping
Contract Pharma, 23 March 2026

DCAT Member Company Announcement Forum 2026: An Inside Look

Mar 23, 2026

With more than six decades of experience in pharmaceutical development and manufacturing, Hovione is an international CDMO offering a comprehensive range of services for New Molecular Entities (NMEs), including drug substances, intermediates, and drug products. The company also supplies niche generic APIs and delivers advanced technologies supporting multiple drug delivery platforms, including oral, injectable, inhalation, and topical formulations.  Today, Hovione employs 2,500 people worldwide and operates 900 m3 of manufacturing capacity across four sites in Europe, the U.S. and Asia. Japan has played an important role in the company’s global strategy since its early years. Initial export activities were followed in 2017 by the establishment of a Japanese subsidiary in Osaka.   Read the full article in Japanese at Yakuji.co.jp Read the article translated in English  

Press Clipping
Yakuji Nippo Magazine, 13 March 2026

International CDMO strengthens its presence in Japan: from active pharmaceutical ingredients to formulations, all at the same location

Mar 13, 2026

In an interview with Executiva, a portuguese media outlet focused on women´s leadership, Diane Villax, co-founder and long-standing leader of Hovione, reflects on her journey and the company’s development over more than six decades. Diane Villax’s career began at a time when few women worked outside the home. At 19, she joined a trading company as a foreign languages correspondent, where she developed essential business skills — including commercial correspondence, banking and export procedures — that later proved instrumental in helping her husband, Ivan Villax, establish Hovione in 1959. From its earliest days operating in the family home in Lisbon, Hovione adopted an international outlook. The company’s first major customers were in Japan, setting demanding quality standards that helped shape its long-term position in global markets. Over the following decades, Hovione expanded its footprint with the construction of its first manufacturing site in Loures (1969), followed by expansion to Macau (1986), the United States (New Jersey, early 2000s) and Ireland (Cork). The company grew into a global organization with more than 2,500 employees — including over 300 scientists — and a reputation as a preferred supplier to leading pharmaceutical companies worldwide. Throughout the interview, Diane highlights the values that have guided the company’s development: a commitment to excellence, a strong work ethic, and a focus on quality and long-term relationships. Although she did not have formal business training, she learned “on the job” and brought discipline, precision and structure to her role — particularly in the company’s early financial and administrative leadership. Now in her nineties and an active member of Hovione’s Board of Directors, Diane Villax remains engaged with the company’s evolution and governance, reflecting a continued commitment to its long-term development. Her story reflects entrepreneurial drive, resilience and long-term leadership — and offers insight into the values that have shaped Hovione’s trajectory for more than six decades. Read the full interview at Executiva.pt (in portuguese).    

Article
Executiva, 23 February 2026

Hovione’s Diane Villax: “I was not brought up to be a business woman”

Feb 23, 2026

Also in Events

See All